0001728328-18-000001.txt : 20180117
0001728328-18-000001.hdr.sgml : 20180117
20180117165951
ACCESSION NUMBER: 0001728328-18-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
EFFECTIVENESS DATE: 20180117
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-303472
FILM NUMBER: 18532076
BUSINESS ADDRESS:
STREET 1: SUITE 340 - 200 GRANVILLE STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1S4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 340 - 200 GRANVILLE STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1S4
D
1
primary_doc.xml
X0708
D
LIVE
0001728328
InMed Pharmaceuticals Inc.
SUITE 340 - 200 GRANVILLE STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
(604) 669-7207
BRITISH COLUMBIA, CANADA
Meridex Network Corporation
Meridex Software Corporation
Cannabis Technologies Inc
None
Corporation
true
Eric
A.
Adams
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Executive Officer
Director
Martin
Bott
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Director
Adam
Cutler
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Director
William
J.
Garner
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Director
Andrew
Hull
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Director
Jeff
Charpentier
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Executive Officer
Sazzad
Hossain
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Executive Officer
Alexandra
D.J.
Mancini
Suite 340 - 200 Granville Street
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 1S4
Executive Officer
Pharmaceuticals
No Revenues
- 06b
false
2018-01-03
true
true
true
true
true
Units, each comprised of one common share and one share purchase warrant exercisable at CAD$1.25 for 18 months
false
0
Canaccord Genuity Corp.
None
Canaccord Genuity Inc.
1020
535 Madison Avenue
New York
NY
NEW YORK
10022
NY
NEW YORK
false
4551022
1633700
2917322
US dollar amounts herein have been converted from Canadian dollars based on the 0.7979 Bank of Canada daily exchange rate in effect on 1-3-18. Total Remaining to be Sold represents the aggregate exercise price of all warrants sold in the offering.
false
2
0
67722
0
true
Proceeds from the offering may be used for general working capital purposes. Thus, proceeds may be used for payments to officers and directors in the ordinary course, but they are not specifically earmarked for such payments.
false
InMed Pharmaceuticals Inc.
/s/ Jeff Charpentier
Jeff Charpentier
Chief Financial Officer
2018-01-17